Search results

Selected filters:

Analysis
Life Sciences

Article type

Topic

Sector

Regions

Year

279 results found for your search

Sort options
14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

13 November 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

07 November 2019

Multi-billion dollar IP dispute exposes dangers of life sciences collaborations

Seattle Genetics is demanding rights to Daiichi Sankyo’s potential blockbuster cancer treatment, which it says is an improvement on the proprietary technology included in their previous partnership

06 November 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate

05 November 2019

Top tips for patenting personalised medicine 

As medical treatments become increasingly bespoke, we reveal some best practices to help inventors secure the highest quality patents possible.

05 November 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds

29 October 2019

Four key IP implications from the rise of orphan drugs

The growing importance of rare disease treatments has strategic, commercial and potential political ramifications for life sciences IP

24 October 2019

Exclusive: Inside the IP protection strategy of an innovative generic

Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets

24 October 2019

Latest statistics show foreign firms win in high numbers at Beijing IP Court

Numbers also show that damages are rising. But litigation statistics only tell part of the story on plaintiff success.

22 October 2019

Trade secrets pitfalls in the life sciences – and how to avoid them

Proprietary information and data are vital sources of commercial advantage for biopharma companies, so keeping them safe is a vitally important task

18 October 2019

Federal Circuit <em>Tarceva</em> decision is good news for oncology patent owners

Appellate court overturns PTAB invalidation, citing uncertainties of R&D in the lucrative cancer space, as well as lack of data in prior art

16 October 2019

WIPO report: US patent filings dip for first time since 2009

The number of grants also drops while UK sees worrying fall in applications; but study has good news for EPO President Campinos

15 October 2019

California’s first-of-a-kind reverse payment law is a further obstacle to litigation settlements

Pharma patent litigation settlements involving the transfer of “anything of value” to the generic are now presumed anti-competitive under Golden State law

14 October 2019

India's patent office appeal board paralysed again

Delhi court refuses to extend chairman’s tenure, leaving the body with just one expert on staff and a growing backlog